Methylation analysis of the glypican 3 gene in embryonal tumours

British Journal of Cancer

Volumn 90, Issue 8, 2004, Pages 1606-1611

  Boily, G ^a,b   Saikali, Z ^a,b   Sinnett, D ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Embryonal tumours; GPC3; Methylation; Transcriptional regulation; X chromosome

Indexed keywords

GENOMIC DNA; GLYPICAN; PROTEOHEPARAN SULFATE;

ARTICLE; CHROMOSOME INACTIVATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEREGULATION; DNA METHYLATION; DOWN REGULATION; EMBRYO; EMBRYONAL CARCINOMA; FEMALE; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SOUTHERN BLOTTING; STATISTICAL SIGNIFICANCE; TRANSCRIPTION REGULATION; X CHROMOSOME LINKAGE; COMPARATIVE STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; KIDNEY TUMOR; METABOLISM; NEPHROBLASTOMA; NEUROBLASTOMA; PATHOLOGY; X CHROMOSOME;

BLOTTING, SOUTHERN; CHROMOSOMES, HUMAN, X; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYPICANS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; KIDNEY NEOPLASMS; MALE; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; WILMS TUMOR;

EID: 2442630304     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601716     Document Type: Article

References (26)

1. Baylín SB, Herman JG, Graff JR, Vertino PM, Issa JP (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72: 141-196
2. Bearzatto A, Szadkowski M, Macpherson P, Jiricny J, Karran P (2000) Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents. Cancer Res 60: 3262-3270
3. Benachenhou N, Guiral S, Gorska-Flipot I, Michalski R, Labuda D, Sinnett D (1998) Allelic losses and DNA methylation at DNA mismatch repair loci in sporadic colorectal cancer. Carcinogenesis 19: 1925-1929
4. Cano-Gauci DF, Song HH, Yang H, McKerlie C, Choo B, Shi W, Pullano R, Piscione TD, Grisaru S, Soon S, Sedlackova L, Tanswell AK, Mak TW, Yeger H, Lockwood GA, Rosenblum ND, Filmus J (1999) Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome. J Cell Biol 146: 255-264
5. Cote S, Sinnett D, Momparler RL (1998) Demethylation by 5-aza-2′-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells. Anticancer Drugs 9: 743-750
6. Filmus J (2001) Glypicans in growth control and cancer. Glycobiology 11: 19R-23R
7. Filmus J, Church JG, Buick RN (1988) Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine. Mol Cell Biol 8: 4243-4249
8. Harrison J, Stirzaker C, Clark SJ (1998) Cytosines adjacent to methylated CpG sites can be partially resistant to conversion in genomic bisulfite sequencing leading to methylation artifacts. Anal Biochem 264: 129-132
9. Hsu HC, Cheng W, Lai PL (1997) Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution. Cancer Res 57: 5179-5184
10. Huber R, Crisponi L, Mazzarella R, Chen CN, Su Y, Shizuya H, Chen EY, Cao A, Pilia G (1997) Analysis of ezon/intron structure and 400 kb of genomic sequence surrounding the 5′-promoter and 3′-terminal ends of the human glypican 3 (GPC3) gene. Genomics 45: 48-58
11. Huber R, Hansen RS, Strazzullo M, Pengue G, Mazzarella R, D'Urso M, Schlessinger D, Pilia G, Gartler SM, D'Esposito M (1999) DNA methylation in transcriptional repression of two differentially expressed X-linked genes, GPC3 and SYBL1. Proc Natl Acad Sci USA 96: 616-621
12. Lage H, Dietel M, Froschle G, Reymann A (1998) Expression of the novel mitoxantrone resistance associated gene MXR7 in colorectal malignancies. Int J Clin Pharmacol Ther 36: 58-60
13. Lin H, Huber R, Schlessinger D, Morin PJ (1999) Frequent silencing of the GPC3 gene in ovarian cancer cell lines. Cancer Res 59: 807-810
14. Midorikawa Y, Ishikawa S, Iwanari H, Imamura T, Sakamoto H, Miyazono K, Kodama T, Makuuchi M, Aburatani H (2003) Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int J Cancer 103: 455-465
15. Momparler RL, Bovenzi V (2000) DNA methylation and cancer. J Cell Physiol 183: 145-154
16. Monk M (1986) Methylation and the X chromosome. BioEssays 4: 204-208
17. Murthy SS, Shen T, De Rienzo A, Lee WC, Ferriola PC, Jhanwar SC, Mossman BT, Filmus J, Testa JR (2000) Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma. Oncogene 19: 410-416
18. Pellegrini M, Pilia G, Pantano S, Lucchini F, Uda M, Furni M, Cao A, Schlessinger D, Forabosco A (1998) Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome. Dev Dyn 213: 431-439
19. Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R, Neri G, Cao A, Forabosco A, Schlessinger D (1996) Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet 12: 241-247
20. Robertson KD, Jones PA (2000) DNA methylation: past, present and future directions. Carcinogenesis 21: 461-467
21. Saikali Z, Sinnett D (2000) Expression of glypican 3 (GPC3) in embryonal tumors. Int J Cancer 89: 418-422
22. Shen T, Sonoda G, Hamid J, Li M, Filmus J, Buick RN, Testa JR (1997) Mapping of the Simpson-Golabi-Behmel overgrowth syndrome gene (GPC3) to chromosome X in human and rat by fluorescence in situ hybridization. Mamm Genome 8: 72
23. Toretsky JA, Zitomersky NL, Eskenari AE, Voigt RW, Strauch ED, Sun CC, Huber R, Meltzer SJ, Schlessinger D (2001) Glypican-3 expression in Wilms tumor and hepatoblastoma. J Pediatr Hematol Oncol 23: 496-499
24. Weksberg R, Squire JA, Templeton DM (1996) Glypicans: a growing trend. Nat Genet 12: 225-227
25. Xiang YY, Ladeda V, Filmus J (2001) Glypican-3 expression is silenced in human breast cancer. Oncogene 20: 7408-7412
26. Zhu ZW, Friess H, Wang L, Abou-Shady M, Zimmermann A, Lander AD, Korc M, Kleeff J, Buchler MW (2001) Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders. Gut 48: 558-564